In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients
- PMID: 33164893
- PMCID: PMC9893338
- DOI: 10.4244/EIJ-D-20-00935
In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients
Abstract
Aims: The aim of this study was to assess clinical and prognosis differences in patients with COVID-19 and STEMI.
Methods and results: Using a nationwide registry of consecutive patients managed within 42 specific STEMI care networks, we compared patient and procedure characteristics and in-hospital outcomes in two different cohorts, according to whether or not they had COVID-19. Among 1,010 consecutive STEMI patients, 91 were identified as having COVID-19 (9.0%). With the exception of smoking status (more frequent in non-COVID-19 patients) and previous coronary artery disease (more frequent in COVID-19 patients), clinical characteristics were similar between the groups, but COVID-19 patients had more heart failure on arrival (31.9% vs 18.4%, p=0.002). Mechanical thrombectomy (44% vs 33.5%, p=0.046) and GP IIb/IIIa inhibitor administration (20.9% vs 11.2%, p=0.007) were more frequent in COVID-19 patients, who had an increased in-hospital mortality (23.1% vs 5.7%, p<0.0001), that remained consistent after adjustment for age, sex, Killip class and ischaemic time (OR 4.85, 95% CI: 2.04-11.51; p<0.001). COVID-19 patients had an increase of stent thrombosis (3.3% vs 0.8%, p=0.020) and cardiogenic shock development after PCI (9.9% vs 3.8%, p=0.007).
Conclusions: Our study revealed a significant increase in in-hospital mortality, stent thrombosis and cardiogenic shock development after PCI in patients with STEMI and COVID-19 in comparison with contemporaneous non-COVID-19 STEMI patients.
Conflict of interest statement
A. Perez de Prado has received personal fees from iVascular, Boston Scientific, Terumo, B. Braun, and Abbott, outside the submitted work. A. Cequier has received grants and personal fees from Abbott Vascular, Medtronic and Biosensors; grants from Boston Scientific, Biomenco, Cordis, OrbusNeich and Spanish Society of Cardiology; personal fees from Ferrer International, Terumo and AstraZeneca, all outside the submitted work. The other authors have no conflicts of interest to declare.
Figures




References
-
- Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, Ibrahim H, Friedman GH, Thompson C, Alviar CL, Chadow HL, Fishman GI, Reynolds HR, Keller N, Hochman JS. ST-Segment Elevation in Patients with Covid-19 - A Case Series. N Engl J Med. 2020;382:2478–80. doi: 10.1056/NEJMc2009020. - DOI - PMC - PubMed
-
- Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, Metra M, Curello S, Maffeo D, Pero G, Cacucci M, Assanelli E, Bellini B, Russo F, Ielasi A, Tespili M, Danzi GB, Vandoni P, Bollati M, Barbieri L, Oreglia J, Lettieri C, Cremonesi A, Carugo S, Reimers B, Condorelli G, Chieffo A. ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020;141:2113–6. doi: 10.1161/CIRCULATIONAHA.120.047525. - DOI - PMC - PubMed
-
- Cid-Alvarez AB, Rodriguez-Leor O, Moreno R, Perez de Prado A. Spanish Cardiac Catheterization and Coronary Intervention Registry. 28th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2018). Rev Esp Cardiol (Engl Ed) 2019;72:1043–53. doi: 10.1016/j.recesp.2019.07.023. - DOI - PubMed
-
- Boletín Oficial del Estado núm. 67, de 14 de marzo de 2020, páginas 25390-25400. Sección I. Disposiciones generales. [Text in Spanish]. 2020. Jun 29, https://www.boe.es/eli/es/rd/2020/03/14/463.
-
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–77. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous